Dear Reader's Of Grow Mudra,  For the third consecutive week, Indian markets ended in the red, facing multiple challenges. A mix of weaker-than-expected quarterly earnings, persistent foreign institutional investor (FII) outflows, and the ongoing Middle East tensions contributed to the decline. While the BSE Sensex dipped by 0.19%, the Nifty50 lost 0.44%, and the mid-cap index shed 1%. However, ...

Shares of Premier Energies gained as much as 10 percent on October 14 after the company's subsidiaries Premier Energies International Private Ltd and Premier Energies Photovoltaic Private Ltd — secured multiple orders, cumulatively worth Rs 765 crore.This includes Rs 632 crore orders for solar modules and orders worth Rs 133 crore for solar cells. The electrical equipment maker added that the su...

The market attempted to extend the previous day's rally but selling pressure in late trade pulled it down to close marginally lower on October 9. However, the market breadth remained positive due to buying in the broader space, with about 1,708 shares advancing against 802 declining shares on the NSE. Volatility is expected to continue in the market, with support at the current week's low. Below a...

Brokerage firm Investec has kept a bullish stance on drugmaker Cipla, banked on expectations of mid-teens growth in the India pharma market, and easing regulatory challenges at its Goa plant.The brokerage remains optimistic of Cipla achieving 12-13 percent on-year growth in sales within the Indian pharma market. Alongside that, Investec also sees a classification from the US Food and Drug Administ...

Cipla Ltd shares have been making higher highs and higher lows, indicating bullish signals across all major time frames. The pharma sector has been in the limelight for the past few sessions, with Nifty Pharma reaching a 52-week high at 19,771.According to Arun Kumar Mantri, Founder of Mantri Finmart, "The stock-specific volumes have been encouraging in the latest bullish move, followed by good pr...